PubMed · Blood· Mazyar Shadman·2026-11-05 08:00· 3 天前

临床试验：CD20-directed Autologous CAR T-cell Therapy for Waldenström Macroglobulinemia.

CD20-directed Autologous CAR T-cell Therapy for Waldenström Macroglobulinemia.

AI 导读

原文摘录：No chimeric antigen receptor therapy (CAR-T) is currently approved for WM. This study assessed safety and efficacy of CD20-targeted CAR-T in BTKi-refractory, heavily pre-treated WM patients.

来源：PubMed · Blood · pubmed.ncbi.nlm.nih.gov

ClinicalTrials.gov 审批与标签 #获批/审批 #ClinicalTrials.gov